Baker Bros. Advisors’s Skye Bioscience SKYE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$6.06M Hold
1,450,638
0.06% 63
2025
Q1
$2.31M Hold
1,450,638
0.03% 72
2024
Q4
$4.11M Buy
1,450,638
+16,004
+1% +$45.3K 0.04% 74
2024
Q3
$5.61M Buy
1,434,634
+934,634
+187% +$3.65M 0.06% 64
2024
Q2
$4.01M Buy
+500,000
New +$4.01M 0.05% 72